The immunology and immunopathology of COVID-19
- PMID: 35271343
- DOI: 10.1126/science.abm8108
The immunology and immunopathology of COVID-19
Abstract
Considerable research effort has been made worldwide to decipher the immune response triggered upon severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, identify the drivers of severe and fatal COVID-19, and understand what leads to the prolongation of symptoms after disease resolution. We review the results of almost 2 years of COVID-19 immunology research and discuss definitive findings and remaining questions regarding our understanding of COVID-19 pathophysiology. We discuss emerging understanding of differences in immune responses seen in those with and without Long Covid syndrome, also known as post-acute sequelae of SARS-CoV-2. We hope that the knowledge gained from this COVID-19 research will be applied in studies of inflammatory processes involved in critical and chronic illnesses, which remain a major unmet need.
Similar articles
-
The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.Pulmonology. 2021 Sep-Oct;27(5):423-437. doi: 10.1016/j.pulmoe.2021.03.008. Epub 2021 Apr 9. Pulmonology. 2021. PMID: 33867315 Free PMC article. Review.
-
Innate immunity in COVID-19: Drivers of pathogenesis and potential therapeutic targets.Asian Pac J Allergy Immunol. 2021 Jun;39(2):69-77. doi: 10.12932/AP-130121-1037. Asian Pac J Allergy Immunol. 2021. PMID: 34174806 Review.
-
The role and delicate balance of Host Immunity in Coronavirus Disease-19.Iran J Immunol. 2021 Mar;18(1):1-12. doi: 10.22034/iji.2021.88526.1874. Iran J Immunol. 2021. PMID: 33787510
-
Innate and adaptive immune responses against coronavirus.Biomed Pharmacother. 2020 Dec;132:110859. doi: 10.1016/j.biopha.2020.110859. Epub 2020 Oct 22. Biomed Pharmacother. 2020. PMID: 33120236 Free PMC article. Review.
-
Pathogenesis-directed therapy of 2019 novel coronavirus disease.J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10. J Med Virol. 2021. PMID: 33073355 Review.
Cited by
-
SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 condition.NPJ Vaccines. 2024 Feb 5;9(1):23. doi: 10.1038/s41541-024-00815-1. NPJ Vaccines. 2024. PMID: 38316833 Free PMC article.
-
Editorial: COVID-19 epidemiological situation as a psychosocial determinant of trauma and stress.Front Psychol. 2024 Jan 10;14:1352269. doi: 10.3389/fpsyg.2023.1352269. eCollection 2023. Front Psychol. 2024. PMID: 38268806 Free PMC article. No abstract available.
-
A Prospective Multicenter Longitudinal Analysis of Suicidal Ideation among Long-COVID-19 Patients.Healthcare (Basel). 2024 Jan 23;12(3):290. doi: 10.3390/healthcare12030290. Healthcare (Basel). 2024. PMID: 38338174 Free PMC article.
-
Long-term outcomes in COVID-19 patients who recovered from the first wave of the pandemic.Natl Sci Rev. 2022 Sep 20;9(11):nwac192. doi: 10.1093/nsr/nwac192. eCollection 2022 Nov. Natl Sci Rev. 2022. PMID: 36478734 Free PMC article.
-
Reduced monocyte proportions and responsiveness in convalescent COVID-19 patients.Front Immunol. 2024 Jan 4;14:1329026. doi: 10.3389/fimmu.2023.1329026. eCollection 2023. Front Immunol. 2024. PMID: 38250080 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous